Versuchen Sie es noch einmal mit einem anderen Suchbegriff
Der aktiv verwaltete Aktienfonds basiert auf einer überzeugenden aktiven Titelselektion. Das Aktienportefeuille investiert in Unternehmen aus China, Hongkong und Taiwan. Der Fonds ist über Sektoren diversifiziert. Der Fonds setzt auf eine disziplinierte Anlagephilosophie und einen global integrierten, modernen Fundamentalresearch.
Name | Titel | Seit | Bis |
---|---|---|---|
Morris Wu | Research Analyst | 2019 | Aktuell |
Biografie | Morris is a member of the Global Emerging Markets and Asia Pacific Equities team and is responsible for investment analysis of China/Hong Kong equities. Morris joined UBS Global Asset Management in May 2015. Prior to this, he was a consulting director at BDA China, providing investment advisory services to top tier hedge funds and private equity funds for their investments in China. Morris worked at BDA for 9 years and specialized in the Consumer and TMT sectors. | ||
Denise Cheung | - | 2018 | Aktuell |
Bin Shi | Portfolio Manager | 2015 | Aktuell |
Biografie | Bin Shi is a member of the Global Emerging Market and Asia Pacific Equities team, located in Hong Kong. He is Country Analyst and Portfolio Manager for China with a focus on Chinese stocks listed on both the overseas and domestic Chinese stock exchanges. Prior to joining UBS Asset Management, Bin spent three years as Head of Int’l Business, portfolio manager and analyst with Boshi Fund Management Co., one of the largest domestic mutual fund companies in China. Prior to that, he worked in the US for eight years as portfolio manager and analyst for several US mutual fund firms. Bin joined UBS in January 2006 and has managed the Greater China Fund since April 2006. | ||
Yu Zhang | - | 2018 | 2019 |
Derrick Sun | - | 2018 | 2018 |
Biografie | Derrick Sun is a member of the Global Emerging Markets and Asian Pacific Equities team and is responsible for investment analysis of China/Hong Kong Equities. Derrick joined UBS Asset Management in July 2013. Prior to this, he was head of research for healthcare and small & mid-cap with Bank of China International (BOCI) and BNP Paribas. Previous industry experience includes 5 years managing a bio-pharmaceutical company’s Shanghai subsidiary and 5 years in Deloitte Consulting (US) where he provided business consulting services to Fortune 500 healthcare and consumer companies. | ||
Projit Chatterjee | - | 2006 | 2018 |
Biografie | Projit Chatterjee is a Senior Equity Specialist within the Global Emerging Markets and Asia Pacific Equities team at UBS Asset Management, based in Singapore. He is also a member of the Global Emerging Markets Strategy Committee and co-manager of the GEM High Dividend funds. Projit has primary responsibility for overall product positioning and development of Emerging Markets and Asian Equity strategies, as well as marketing and communication of these strategies to existing and prospective clients globally. Projit joined UBS in 1997 as a Corporate Finance Analyst with UBS Investment Bank in Mumbai, India. In 1999, he moved to UBS Asset Management in Zurich to work in Strategic Projects, International Fund Marketing. In Zurich, Projit held various roles in the areas of strategic business development, business management and investment solutions. He also led an acquisition project in the Indian market. Before joining UBS, Projit worked as a money market and foreign exchange dealer in the treasury of MashreqBank, a UAE bank in Mumbai. | ||
Hai Huang | - | 2010 | 2015 |
Sind Sie sicher, dass Sie %USER_NAME% sperren möchten?
Dadurch werden Sie und %USER_NAME% nicht mehr in der Lage sein, Beiträge des jeweils anderen auf Investing.com zu sehen.
%USER_NAME% wurde erfolgreich zu Ihrer Sperrliste hinzugefügt.
Da Sie diese Person entsperrt haben, müssen Sie 48 Stunden warten, bevor Sie sie wieder sperren können.
Sagen Sie uns Ihre Meinung zu diesem Kommentar
Vielen Dank!
Ihre Meldung wurde zur Überprüfung an unsere Moderatoren geschickt